Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients

Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients

Objectives: To evaluate the safety of antimotility agents (AAs) in a population of patients with hematologic malignancies and concurrent Clostridioides difficile infection (CDI) and to describe the outcomes of AA use in a hospital setting. Patients and Methods: We used the electronic health record t...

Full description

Bibliographic Details
Main Authors: Carla Kuon, MD, Rae Wannier, MPH, David Sterken, MD, Margaret C. Fang, MD, MPH, Jeffrey Wolf, MD, Priya A. Prasad, PhD, MPH
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454820301077

Internet

http://www.sciencedirect.com/science/article/pii/S2542454820301077

Similar Items